Altretamine

Altretamine (trade name Hexalen), also called hexamethylmelamine, is an antineoplastic agent. It was approved by the U.S. FDA in 1990. Contents 1 Uses 2 Mechanism 3 Side effects 4 Interactions 5 See also 6 References Uses It is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with cisplatin and/or alkylating agent-based combination.[1] It is not considered a first-line tr... [wikipedia]